Background: |
May modulate activity of cullin-RING E3 ubiquitin ligase (CRL) complexes (PubMed:21778237). May down-regulate activation of NF-kappa-B (PubMed:15799966). Modulates Na+ transport in epithelial cells by regulation of apical cell surface expression of amiloride-sensitive sodium channel (ENaC) subunits (PubMed:23637203). |
Applications: |
ELISA, IHC |
Name of antibody: |
COMMD9 |
Immunogen: |
Fusion protein of human COMMD9 |
Full name: |
COMM domain containing 9 |
Synonyms: |
HSPC166; C11orf55; LINC00610 |
SwissProt: |
Q9P000 |
ELISA Recommended dilution: |
5000-10000 |
IHC positive control: |
Human cervical cancer and Human tonsil |
IHC Recommend dilution: |
50-200 |